Gossamer Bio (GOSS) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $180.2 million.
- Gossamer Bio's Cash & Current Investments fell 4489.14% to $180.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.2 million, marking a year-over-year decrease of 4489.14%. This contributed to the annual value of $294.5 million for FY2024, which is 64.33% down from last year.
- Gossamer Bio's Cash & Current Investments amounted to $180.2 million in Q3 2025, which was down 4489.14% from $212.9 million recorded in Q2 2025.
- Gossamer Bio's 5-year Cash & Current Investments high stood at $354.5 million for Q2 2024, and its period low was $162.1 million during Q2 2023.
- Over the past 4 years, Gossamer Bio's median Cash & Current Investments value was $257.9 million (recorded in 2025), while the average stood at $261.0 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 11864.97% in 2024, then plummeted by 4489.14% in 2025.
- Over the past 4 years, Gossamer Bio's Cash & Current Investments (Quarter) stood at $255.7 million in 2022, then rose by 15.94% to $296.4 million in 2023, then fell by 0.64% to $294.5 million in 2024, then tumbled by 38.81% to $180.2 million in 2025.
- Its Cash & Current Investments was $180.2 million in Q3 2025, compared to $212.9 million in Q2 2025 and $257.9 million in Q1 2025.